Vireo has been working for the past decade to establish safety and support commercialization for microfibrillated cellulose, cellulose nanocrystals and a host of other emerging biomaterials. Our lead scientists are sharing their experience and provide practical guidance in presentations, posters, discussion panels and networking events at the 2023 TAPPI Nanotechnology Conference.

The last few weeks have seen a number of announcements related to nano and sustainable materials testing, regulation and commercialization. These are some of the top stories that caught our eyes:

At Vireo, we keep close surveillance on commercialization and regulatory developments in cultured and alt-protein meat and seafood, and we have rarely seen as much activity as this! Here is our roundup of the latest developments…

In recent weeks we have seen U.S. Senators call climate change ‘ideology’, but overwhelming evidence reveals climate change as a real business risk – one that can, and must, be managed. At Vireo, we are working to gain market and regulatory acceptance of biobased, recycled, and advanced technologies that lower these risks.

An $80 million grant from the US DOE  will allow AVAPCO LLC to ramp up production bioethanol and nanocellulose by upcycling woody residue from sawmills, paper, and pulp plants. Life cycle analysis provides  a valuable tool for assessing the climate change and environmental  benefits.